WEXFORD, Pa. - Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP), known for its work in cell therapy for various diseases, has announced a significant rebranding to COEPTIS, signaling a strategic shift to encompass technology and artificial intelligence (AI) alongside its biopharmaceutical endeavors.